KYMR earnings: next report 2026-08-10, real EPS beat/miss history, analyst consensus Buy, P/E -30.82. Updated 2026-07-23.
Kymera Therapeutics (KYMR) Research Hub
Kymera Therapeutics (KYMR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 114.96 USD (-0.41%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -30.82, market cap 9.10B. This hub links to the full technical, earnings and options research available for KYMR.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 114.96 USD (-0.41%) |
| 52-week range | 84.84 USD – 127.85 USD |
| Trend regime | Range |
| 14-day RSI | 57.8 (Bullish) |
| Trailing P/E | -30.82 |
| Market cap | 9.10B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-10 |
Available research for KYMR
Covered Call on KYMR: how it works, illustrative setup around the real 114.96 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on KYMR: how it works, illustrative setup around the real 114.96 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on KYMR: how it works, illustrative setup around the real 114.96 USD price, max profit/loss, breakeven and when to use it. Educational.
KYMR technical analysis: range, last 114.96 USD, RSI 57.8, 52w range 84.84 USD–127.85 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is KYMR in?
Kymera Therapeutics (KYMR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is KYMR in an uptrend or downtrend?
As of 2026-09-11, KYMR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is KYMR's trailing P/E ratio?
KYMR's trailing P/E is -30.82, with a market cap of 9.10B. See the earnings research page for full valuation detail.
When does KYMR next report earnings?
KYMR is next scheduled to report earnings on 2026-08-10, with a consensus EPS estimate of -0.71706 USD.